Bruck Claudine 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Jan 14, 2021
Insider Transaction Report
Form 4
Bruck Claudine
Director
Transactions
- Award
Stock Option
2021-01-13$0.00/sh+2,500$3→ 2,500 totalExercise: $2.28From: 2022-01-13Exp: 2031-01-13→ Common Stock (2,500 underlying) - Award
Common Stock
2021-01-13$0.00/sh+2,500$3→ 12,550 total
Footnotes (1)
- [F1]Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest on the one-year anniversary of the date of grant.